PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.\', \'Cheng Lab, Suzhou Institute of Systems Medicine, Suzhou, China.\', \'Department of Laboratory Medicine, TaiHe Hospital, Hubei University of Medicine, Shiyan, China.\', \'Department of Scientific Research, Suzhou Func Biotech Inc, Suzhou, China.\', \'Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States.\', \'Department of Surgery, Affiliated Tumor Hospital of Nantong University, Nantong, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2020.602395
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33488599
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all